Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor
Yoshio Endo1, Tohru Obata, Daigo Murata
1Department of Experimental Therapeutics, Cancer Research Institute, Kanazawa University, Kanazawa 920-0934, Japan. yendo@kenroku.kanazawa-u.ac.jp
Abstract:
Nucleoside transporters play an important role in the disposition of nucleosides and their analogs. To elucidate the relationship between chemosensitivity to antitumor nucleosides and the functional expression of equilibrative nucleoside transporters (ENT), we established stable cell lines of human fibrosarcoma HT-1080 and gastric carcinoma TMK-1 that constitutively overexpressed green fluorescent protein-tagged hENT1, hENT2, hENT3 and hENT4. Both hENT1 and hENT2 were predictably localized to the plasma membrane, whereas hENT3 and hENT4 were localized to the intracellular organelles. The chemosensitivity of TMK-1 cells expressing hENT1 and hENT2 to cytarabine and 1-(3-C-ethynyl-beta-D-ribopentofuranosyl) cytosine increased markedly in comparison to that of mock cells. However, no remarkable changes in sensitivity to antitumor nucleosides were observed in cell lines that expressed both hENT3 and hENT4. These data suggest that hENT3 and hENT4, which are mainly located in the intracellular organelles, are not prominent nucleoside transporters like hENT1 and hENT2, which are responsible for antitumor nucleoside uptake.
Insights
Equilibrative nucleoside transporters (ENTs) impact antitumor drug effectiveness. Researchers found that hENT1 and hENT2, located on the cell surface, significantly enhanced sensitivity to nucleoside-based chemotherapy, unlike intracellular hENT3 and hENT4.
Area of Science:
- Pharmacology
- Molecular Biology
- Cell Biology
Background:
- Nucleoside transporters are crucial for the cellular uptake and disposition of nucleosides and their analogs.
- Antitumor nucleosides are a significant class of chemotherapeutic agents, and their efficacy is often influenced by transporter expression.
Purpose of the Study:
- To investigate the functional roles of specific equilibrative nucleoside transporters (ENTs) in mediating cellular chemosensitivity to antitumor nucleosides.
- To determine the subcellular localization and functional impact of human ENT1, ENT2, ENT3, and ENT4 on cancer cell lines.
Main Methods:
- Stable cell lines (HT-1080 and TMK-1) were engineered to overexpress green fluorescent protein-tagged human ENT1, ENT2, ENT3, and ENT4.
- Subcellular localization of the overexpressed transporters was assessed.
- Chemosensitivity assays were performed using established antitumor nucleosides (cytarabine and a related analog) on engineered cell lines compared to mock-transfected controls.
Main Results:
- hENT1 and hENT2 were confirmed to be localized at the plasma membrane, consistent with their role in nucleoside transport.
- hENT3 and hENT4 were primarily localized to intracellular organelles.
- TMK-1 cells overexpressing hENT1 or hENT2 exhibited significantly increased sensitivity to cytarabine and the ethynyl-ribopentofuranosyl cytosine analog.
- Cell lines expressing hENT3 or hENT4 did not show significant alterations in chemosensitivity to these antitumor nucleosides.
Conclusions:
- Plasma membrane-localized equilibrative nucleoside transporters, specifically hENT1 and hENT2, play a critical role in enhancing cellular uptake and chemosensitivity to key antitumor nucleoside drugs.
- Intracellularly localized transporters, hENT3 and hENT4, do not appear to be major contributors to the uptake and efficacy of the tested antitumor nucleosides.
- Targeting hENT1 and hENT2 may represent a viable strategy to improve the therapeutic outcomes of nucleoside-based chemotherapy.
More Related Videos
08:53Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
ABC Transporters: Exporter
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
